Douglas W. Charnas

S&R Technology Holdings LLC provide support to global entrepreneurs and new businesses. It offers managing and growing global ventures. The company was founded by Sachiko Kuno and Ryuji Ueno in 1999 and is headquartered in Bethesda, MD.

Johns Hopkins Medicine, Inc. owns and operates hospitals. It offers health care services in the areas of burn and wound care, cardiac surgery, cardiology, endocrinology, gastroenterology, gynecology/obstetrics, innovation in quality patient care, internal medicine, nephrology, neurology, neurosurgery, oncology, orthopedic surgery, otolaryngology-head and neck surgery. The company was founded by Johns Hopkins in 1997 and is headquartered in Baltimore, MD.

The Maureen and Mike Mansfield Foundation promote understanding and cooperation among nations. The Foundation sponsors exchanges, dialogues and publications that create networks among Asian leaders and U.S. explore the underlying issues influencing public policies and increase awareness about the nations and peoples of Asia. The company was founded in 1983 and is headquartered in Washington, DC.

Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million.

Henry L. Stimson Center operates as a nonpartisan policy research center. The firm works to solve refugee flows, arms trafficking, and terrorism. Its program include conventional defense, global political demography, space security, food security, and environmental security. The company was founded by Barry Blechman and Michael Krepon in 1989 and is headquartered in Washington, DC.

VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD.